Search results for " Intermedi"

showing 10 items of 293 documents

L’accesso ai servizi di retail banking tra innovazione tecnologica e configurazione dei business models degli intermediari bancari

2010

Settore SECS-P/11 - Economia Degli Intermediari Finanziariretail banking innovazione business models intermediari bancari.
researchProduct

Reti d’impresa e banche: profili giuridici ed economico-finanziari

2013

The paper aims to examine the new regulatory framework of firm networks in Italy and its impact on the Italian banks' lending policies. In particular, the paper investigates the uniqueness of the Italian firm networks, and the main economic and financial issues resulting from the evaluation of the creditworthiness of banks.

Settore SECS-P/11 - Economia Degli Intermediari Finanziarireti d'impresa banca credito crisi finanziaria merito creditizio.
researchProduct

Editorial

2016

The purpose of this special issue is to offer different perspectives on finance sustainability and to develop analytical frameworks for the analysis of the drivers of sustainability at a firm and industry level. Financial mechanisms, instruments, markets, risk management techniques, and business models are identified and their interactions are examined and discussed in the following papers.

Settore SECS-P/11 - Economia Degli Intermediari Finanziaririsk management finance banking financial crisis business model financial regulation financial instability.
researchProduct

Gli istituti di pagamento: i nuovi soggetti previsti dalla direttiva europea

2010

Settore SECS-P/11 - Economia Degli Intermediari Finanziarisistema dei pagamenti direttiva europea attività bancaria servizi di pagamento
researchProduct

I processi di standardizzazione della funzione creditizia degli intermediari bancari: aspetti istituzionali, organizzativi e finanziari

2012

This paper aims to point out how standardization and financial innovation are putting under pressure the traditional economics of banking. It is argued that the progressive standardization and information technology innovation, with special reference to internal rating systems, risk management techniques, and regulatory constraints, have been leading bank lending toward new business models. The increasing role of internal ratings, credit scorings, and hard information in the banking intermediation process have enlarged the organizational and strategic differences between transaction-based banking and relationship-based banking. The structure of this paper is as follows. Section 1 outlines t…

Settore SECS-P/11 - Economia Degli Intermediari Finanziaristandardizzazione banca rating rischio credito risk management.
researchProduct

Il rapporto banca-impresa tra transaction banking e relationship banking: la ricerca condotta nella provincia di Caltanissetta.

2016

In questo capitolo saranno esposti i principali contributi teorici ed empirici della letteratura economico-finanziaria sul relationship banking e transaction banking utili alla lettura e interpretazione dei comportamenti aziendali adottati dalle banche nell’esercizio della complessa e articolata funzione creditizia. Infatti, il vario articolarsi della soft e hard information nell’economia e gestione della banca influenza significativamente la valutazione del merito di credito dell’impresa richiedente fondi, gli approcci strategico-organizzativi alle relazioni creditizie banca-impresa e, in ultima analisi, l’efficienza ed efficacia dell’intermediazione creditizia bancaria.

Settore SECS-P/11 - Economia Degli Intermediari Finanziaritransaction banking relationship banking loan market banking hard information soft information credit scoring rating.
researchProduct

Transaction Costs, Standardization and Modularity in Credit Risk Transfer Market

2010

The advent of a credit risk market has profoundly altered the role of banking firms into one of asset originator and asset distributor rather than the asset holder. Banks have traditionally originated and held credit risk. It emphasis the different role of financial institutions from holders of credit risk to originators and distributors of credit risk. In this paper I aim to evaluate how the modularity and the standardization create the precondition for the creation of a credit risk transfer market in the banking industry. The intermediate market of credit risk transfer appears when the banking production processes have become more disintegrated. The vertical disintegration of the banking …

Settore SECS-P/11 - Economia Degli Intermediari Finanziaritransaction costs credit risk modularity standardization.
researchProduct

¿Por qué existen los bancos?

2004

La incorporación reciente a la teoría bancaria contemporánea de las herramientas de análisis de las teorías de la agencia y de la economía de la información ha modificado nuestra visión tradicional del negocio bancario, ampliando las funciones que realizan estos intermediarios. El estudio de estas funciones y de las ventajas comparativas que poseen los bancos en el ejercicio de las mismas constituirá el eje central de nuestro trabajo. De los resultados de este análisis concluiremos que la existencia de los bancos se justifica porque estas entidades, a través de las funciones que realizan, permiten una mejor colocación de los recursos financieros, beneficiando a demandantes y oferentes de fo…

Sistema bancario; Coste de transacción; Información; Riesgo financiero Pagos; Liquidez bancaria; Intermediación financiera; Activos financieros; Pasivos financierosUNESCO::CIENCIAS ECONÓMICAS::Actividad económica::Dinero y operaciones bancarias
researchProduct

Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma.

2017

Background and aims the Barcelona Clinic Liver Cancer intermediate stage (BCLC-B) of hepatocellular carcinoma (HCC) includes extremely heterogeneous patients in terms of tumor burden and liver function. Transarterial-chemoembolization (TACE) is the first-line treatment for these patients although it may be risky/useless for someone, while others could undergo curative treatments. This study assesses the treatment type performed in a large cohort of BCLC-B patients and its outcome. Methods retrospective analysis of 485 consecutive BCLC-B patients from the ITA.LI.CA database diagnosed with naive HCC after 1999. Patients were stratified by treatment. Results 29 patients (6%) were lost to follo…

SorafenibMaleNiacinamidemedicine.medical_specialtyStandard of careCarcinoma HepatocellularAntineoplastic AgentsGastroenterologyIntermediate stage03 medical and health sciences0302 clinical medicineHCC; BCLC-B; Intermediate stage; Treatment; HepatologyInternal medicinemedicineHumansChemoembolization TherapeuticHCCPropensity ScoreAgedNeoplasm StagingRetrospective Studiesintermediate stageHepatologytreatmentbusiness.industryPatient SelectionPhenylurea CompoundsLiver NeoplasmsSettore MED/09 - MEDICINA INTERNAStandard of CareHepatologyMiddle AgedSorafenibmedicine.diseaseSurvival AnalysisTreatment OutcomeItaly030220 oncology & carcinogenesisHepatocellular carcinomaPropensity score matchingMultivariate Analysis030211 gastroenterology & hepatologyFemaleLiver functionLiver cancerbusinessBCLC-Bmedicine.drug
researchProduct

Transarterial chemoembolization and sorafenib in patients with intermediate-stage hepatocellular carcinoma: time to enter routine clinical practice?

2015

According to the guidelines of the European Association for the Study of the Liver (EASL), patients affected from hepatocellular carcinoma (HCC) can be classified according to the Barcelona Clinic Liver Cancer (BCLC) staging system. This classification system divides HCC patients in five stages (0, A, B, C and D) on the basis of a number of prognostic and treatment- related variables such as tumor status and liver function. A specific treat ment approach is then proposed for each of the above-mentioned stages. Transarterial chemoembolization (TACE) is recommended as first-line therapy in the treatment of patients with intermediate-stage (BCLC-B class) HCC [1]. The efficacy of this procedure…

SorafenibOncologyNiacinamideCancer Researchmedicine.medical_specialtyCarcinoma HepatocellularCombination therapyHCC; TACE; combination therapy; intermediate stage; sorafenibAntineoplastic Agentscombination therapyInternal medicineMedicineHumansStage (cooking)Chemoembolization TherapeuticHCCProtein Kinase InhibitorsTACEintermediate stagePerformance statusbusiness.industryPhenylurea CompoundsLiver NeoplasmsGeneral Medicinemedicine.diseaseCombined Modality Therapydigestive system diseasesPortal vein thrombosisSurgeryOncologyHepatocellular carcinomasorafenibLiver functionbusinessLiver cancermedicine.drug
researchProduct